Europe PMC
open access
CC BY 4.0
Tissue-based methylation testing as a predictor of clinical regression in patients with high- grade cervical intraepithelial neoplasia (CIN2/3)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study#966245
- The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2)#904705
- CASUS: Validation for Detection of Precursor Lesions#1095306
- Comparison of Moducare versus Wait-and-See approach for histologically proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) (MODUCIN1 TRIAL) – Study protocol#365135
- Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection#1138425
Record · ID 624433
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive